Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies. - Wikidata - awgldk - TriplyDB

Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies.

Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies.

http://www.wikidata.org/entity/Q36994508

about

Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis.Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients.PD-L1 and intratumoral immune response in breast cancer.Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers.Type Iγ phosphatidylinositol phosphate kinase regulates PD-L1 expression by activating NF-κB.Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer.Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification.Emerging biomarkers for PD-1 pathway cancer therapy.Immunotherapy for Breast Cancer: Current and Future Strategies.Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients.

P2860

Q36358014-F9611E8C-3AAC-4D3E-BAA3-CA85EEDD42C5 Q37691082-70891DDE-9608-414B-83EF-F07E7FAF45E1 Q41612935-19B9159F-3F74-4D44-BA7C-72AFED277BA0 Q41708934-BEAFF3EB-6138-411F-BABA-0E7E66EFBE80 Q41964740-69A9370C-C9E6-4C9B-8AA1-99E1E6A7C0DC Q47763725-CC7CA814-3384-4EAE-8627-3D6CA71FBDAA Q48330476-4ED29C99-61E4-4E71-AAF2-9D464856B898 Q51275962-C94333BD-C703-400A-8C30-6A3C027850BA Q52587066-FD5A2032-8CCD-440A-9535-17EF1302C162 Q52733772-DDD698AD-20B2-48EC-8610-E7B53482AA11

P2860

Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies.

http://www.wikidata.org/entity/Q36994508

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Expression of PD-L1 in triple- ...... mmunohistochemical antibodies.

@en

type

label

Expression of PD-L1 in triple- ...... mmunohistochemical antibodies.

@en

prefLabel

Expression of PD-L1 in triple- ...... mmunohistochemical antibodies.

@en

P1433

Q36994508-F563B669-5CA7-4F89-9F75-03EEA0D9892C

P1476

Q36994508-19361247-03AC-472D-8B6D-CAB255BAE922

P2093

Q36994508-3BA622E3-C01C-444F-8C55-A717E58A9BAF

Q36994508-9708CFBF-6666-4AFF-AA38-3F359A4E851E

P2860

Q36994508-0C069C14-7416-4978-8CF9-06D972E4415B

Q36994508-0C7501AF-8E71-4D7C-A2C5-E3050D1C9A69

Q36994508-0FC81B67-DB4D-4EAC-8A70-1F8BAB970367

Q36994508-135BD135-F3E2-4BD8-80D0-D28F7B26276A

Q36994508-1BC3515D-9F3E-4DC6-9EFB-C04645C34B45

Q36994508-1CD10AB7-50A4-468F-8D3A-16E47351936E

Q36994508-22F37589-4602-4DF0-ABDD-47129A81783B

Q36994508-2E2CC23E-3AD0-4DE5-AF57-17FD19682ECD

Q36994508-309F939E-563E-4CB3-B4CF-3A2F83389F9E

Q36994508-33DF8A44-61E8-4DA2-A676-3A044F600B7D

P2888

Q36994508-52273649-6E41-47C8-A647-7F48991D10B5

P304

Q36994508-F1170A98-6C6A-4D6F-872A-9848DD10F60C

P31

Q36994508-184605D0-3EC4-456E-B868-B36A05C22DCF

P356

Q36994508-3E0CB16D-2AF7-4D3E-9907-FF99BC71F337

P433

Q36994508-70E3AC05-007A-42DC-BB46-614881C8BF13

P478

Q36994508-A1E7EBEF-8FF6-4F19-B71C-2BF08F95D6F4

P50

Q36994508-4A07949E-B666-4BDB-800B-D7079D32957E

P577

Q36994508-01D05117-3237-4575-A224-6C302D460695

P6179

Q36994508-88435D57-EF24-4BE2-AD34-1E6160176AAB

P698

Q36994508-36002E52-97C9-4D65-98B2-78669294D046

P921

Q36994508-4A5AFDFF-5924-4E44-8AC8-1FA5AF3A859B

P932

Q36994508-259F7BE2-F459-4AA6-9980-F53F43F23398

P356

S12967-016-0925-6

P1433

Journal of Translational Medicine

P1476

Expression of PD-L1 in triple- ...... immunohistochemical antibodies

@en

P2093

Woo Young Sun

http://www.w3.org/2001/XMLSchema#string

Yu Kyung Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Molecular portraits of human breast tumours

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

P2888

s12967-016-0925-6

P304

173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-016-0925-6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1018850062

http://www.w3.org/2001/XMLSchema#string

P698

27286842

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

4902914

http://www.w3.org/2001/XMLSchema#string